Buy Urovant Sciences Ltd Stock | UROV Stock Price & Latest News | Public
UROV

Urovant Sciences Ltd

$0.00 (0.00%)Today

    About UROV

    Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on J...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.56
    -1.12
    -1.68
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.67

    Actual EPS
    Q4 2020

    Stats

    Market Cap$315,24M
    Volume2,93k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.98
    1 Year Low$6.55
    Open$9.87
    High$10.01
    Low$9.55

    Buy any stock with any amount of money.

    Download the App
    Download the app